NovoBind is an integrated animal health company utilizing next-generation biologics to target and neutralize key pathogens affecting producers and food safety. We target pathogens that cause >$1B of production losses and have been materially affected by the following:
1) Antibacterial resistance,
2) A Regulatory ban on antibiotics, and;
3) Changing consumer sentiment.
Company Details
- Employees
- 11
- Address
- 1021 West Hastings Mnp Tower, 9th Floor, Vancouver,british Columbia V6e 2e9,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- novobind.com
- Keywords
- Vancouver.
- HQ
- Vancouver , British Columbia
Novobind Questions
Novobind's website is novobind.com
Novobind's LinkedIn profile is https://ca.linkedin.com/company/novobind
Novobind has
11 employees.
View email and phone details for 11
employees at Novobind.
Novobind's industry is
Biotechnology Research
Novobind's top competitors are
Biolytical,
Elysia Creative Biology,
Lds - Learn. Develop. Succeed.,
Abcellera,
Healstone Biotech Inc.,
Lux Bio,
Zymeworks Inc.,
Stemcell Technologies,
Amgen,
Duxagri.
Novobind's categories are Biotechnology Research
